智通财经APP讯,罗欣药业(002793.SZ)披露2025年第一季度报告,报告期公司实现营收4.83亿元,同比下降29.91%;归母净利润565万元,同比扭亏为盈;扣非净利润67万元,同比扭亏为盈。基本每股收益0.01元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.